Skip to main content

Table 1 Stable Clonotypes.

From: Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells

Clonotypes Ex Vivo IPP Expand
DONOR: ND001 2007 2008 2007 2008
CALW         SR         ELG 52 34 13 21
CALWE         A         ELG 14 28 11 14
CALWE         RK         QELG <3 <3 6 3
CALWEV      RK         LG 3 6 5 9
CALWEV               QELG 4 <3 5 4
CALWE         T      QELG <3 <3 11 21
CALWE         TE   QELG <3 <3 6 10
N 165 158 151 239
DONOR: ND006     
CALWEV               QELG 11 13 11 13
CALWE         AK      ELG <3 9 5 10
CALWE         A      QELG 11 6 5 12
CALWEV      R         ELG <3 4 6 4
N 156 206 186 287
DONOR: ND019     
CALWEV      D         ELG 28 36 36 23
CALWE      PQ      QELG 10 5 4 7
CALWEV               QELG 7 9 4 7
CALWEV   R            ELG 6 3 3 8
CALWE      A         QELG 8 8 9 5
CALWE      IE      QELG <3 <3 6 5
N 163 256 166 246
  1. Vγ2 chain clonotypes (CDR3 region) are shown for donors ND001, ND006 and ND019. For each clonotype, we show the proportion of all Vγ2 chains represented by that clonotype for specimens collected in 2007 or 2008. Clonotype abundance for ex vivo and post-expansion samples are shown. The N values represent the total number of Vγ2 chain DNA sequences obtained for each specimen.